Research Library
Compound Research Profiles·Compound Research·4 min read

SLU-PP-332 Is Not a Peptide: ERR Agonism and Exercise-Mimetic Research

SLU-PP-332 should not be marketed as a peptide and exercise-mimetic language should be read as research shorthand.

By
Jacob Leisher, Researcher, Cendrix
Reviewed by
Jacob Doyon, Researcher, Cendrix
Published
June 4, 2026
Last reviewed
June 26, 2026

The molecule belongs to a different class

SLU-PP-332 is not composed of amino acids and should not be marketed or discussed as a peptide. It is a synthetic small molecule designed around estrogen-related receptor pharmacology.

ERRs are metabolic transcription factors

Estrogen-related receptors regulate transcriptional programs linked to mitochondrial function, oxidative metabolism, and energy use. Despite the name, they are orphan nuclear receptors and not simply estrogen receptors.

Exercise-mimetic language needs restraint

Animal studies have reported changes in endurance-related and metabolic endpoints. Exercise mimetic is a research shorthand, not evidence that a compound reproduces the systemic benefits, adaptations, or safety profile of physical activity in humans.

The evidence is early

Available research is preclinical. Human bioavailability, target selectivity, metabolism, toxicology, reproductive effects, carcinogenicity, and long-term consequences are not established.

This article is provided for scientific and educational purposes. It does not describe or recommend human or veterinary use. Research findings may be limited by study design, model selection, material identity, sample size, or lack of independent replication.

Cendrix analysis

Cendrix describes SLU-PP-332 as an early-stage ERR agonist research chemical, not as an exercise substitute and not as a peptide.

Selected primary references

  1. [1]PubMed: SLU-PP-332
  2. [2]PubMed: ERR agonist metabolism
  3. [3]Therapeutic peptides review for classification context

Editorial note. Written by Jacob Leisher and scientifically reviewed by Jacob Doyon. See our editorial standards, citation policy, and corrections policy.